Viking, CRISPR, Cytokinetics are M&A targets: Wells Fargo seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
24-week ensifentrine improves dyspnea in moderate to severe COPD healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Vectura Group (OTCMKTS:VEGPF – Get Free Report) and Verona Pharma (NASDAQ:VRNA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations and dividends. Risk & Volatility Vectura Group has a […]
Verona Pharma (NASDAQ:VRNA – Free Report) had its price objective cut by HC Wainwright from $33.00 to $30.00 in a research note published on Monday morning, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Verona Pharma’s FY2024 earnings at ($1.36) EPS, Q1 2025 earnings at ($0.24) […]